The effect of anti-spore antibody responses on the use of spores for vaccine delivery

Vaccine

Volumn 27, Issue 34, 2009, Pages 4576-4584

  Yu, Li Hua ^a   Cutting, Simon M ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bacillus subtilis; Mucosal vaccine; Phagocytosis; Spore germination; Spores

Indexed keywords

ANTISERUM; BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LISTERIOLYSIN O; MPT64 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BACILLUS SUBTILIS; BACTERIAL SPORE; CELL ADHESION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SPORE GERMINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACILLUS; BACTERIAL VACCINES; FEMALE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED C57BL; OPSONIN PROTEINS; PHAGOCYTOSIS; SPORES;

EID: 67649487907     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.087     Document Type: Article

References (24)

1. Isticato R., Cangiano G., Tran H.T., Ciabattini A., Medaglini D., Oggioni M.R., et al. Surface display of recombinant proteins on Bacillus subtilis spores. J Bacteriol 183 (2001) 6294-6301
2. Duc L.H., Hong H.A., Atkins H.S., Flick-Smith H.C., Durrani Z., Rijpkema S., et al. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen. Vaccine 25 January (2) (2007) 346-355
3. Zhou Z., Xia H., Hu X., Huang Y., Li Y., Li L., et al. Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis. Vaccine 26 March (15) (2008) 1817-1825
4. Mauriello E.M.F., Duc L.H., Isticato R., Cangiano G., Hong H.A., De Felice M., et al. Display of heterologous antigens on the Bacillus subtilis spore coat using cotc as a fusion partner. Vaccine 22 (2004) 1177-1187
5. Hoang T.H., Hong H.A., Titball R.W., and Cutting S.M. A recombinant Bacillus expressing the C. perfringens alpha-toxoid is a candidate, orally delivered, necrotic enteritis vaccine. Infect Immun 76 11 (2008) 5257-5265
6. Duc L.H., Hong H.A., Fairweather N., Ricca E., and Cutting S.M. Bacterial spores as vaccine vehicles. Infect Immun 71 (2003) 2810-2818
7. Tam N.K., Uyen N.Q., Hong H.A., Duc le H., Hoa T.T., Serra C.R., et al. The intestinal life cycle of Bacillus subtilis and close relatives. J Bacteriol 188 April (7) (2006) 2692-2700
8. Duc L.H., Hong H.A., and Cutting S.M. Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen presentation. Vaccine 21 (2003) 4215-4224
9. Paccez J.D., Nguyen H.D., Luiz W.B., Ferreira R.C., Sbrogio-Almeida M.E., Schuman W., et al. Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Vaccine 25 June (24) (2007) 4671-4680
10. Nicholson W.L., and Setlow P. Sporulation, germination and outgrowth. In: Harwood C.R., and Cutting S.M. (Eds). Molecular biological methods for Bacillus (1990), John Wiley & Sons Ltd., Chichester, UK 391-450
11. Cutting S.M., and Vander-Horn P.B. Genetic analysis. In: Harwood C.R., and Cutting S.M. (Eds). Molecular biological methods for Bacillus (1990), John Wiley & Sons Ltd., Chichester, England 27-74
12. Sambrook J., and Russell D.W. Molecular cloning: a laboratory manual. 3rd ed. (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
13. Youngman P., Perkins J., and Losick R. Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene. Plasmid 12 (1984) 1-9
14. Huang J.M., La Ragione R.M., Cooley W.A., Todryk S., and Cutting S.M. Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses. Vaccine 26 November (48) (2008) 6043-6052
15. Uyen N.Q., Hong H.A., and Cutting S.M. Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles. Vaccine 25 January (2) (2007) 356-365
16. Bergquist C., Lagergard T., Lindblad M., and Holmgren J. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect Immun 63 May (5) (1995) 2021-2025
17. Shen X., Lagergard T., Yang Y., Lindblad M., Fredriksson M., Wallerstrom G., et al. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate. Vaccine 19 May (25-26) (2001) 3360-3368
18. Welkos S., Friedlander A., Weeks S., Little S., and Mendelson I. In vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 51 October (10) (2002) 821-831
19. Donovan W., Zheng L., Sandman K., and Losick R. Genes encoding spore coat polypeptides from Bacillus subtilis. J Mol Biol 196 (1987) 1-10
20. Cote C.K., Rossi C.A., Kang A.S., Morrow P.R., Lee J.S., and Welkos S.L. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog 38 May-June (5-6) (2005) 209-225
21. Welkos S., Little S., Friedlander A., Fritz D., and Fellows P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147 (2001) 1677-1685
22. Moir A., and Smith D.A. The genetics of bacterial spore germination. Ann Rev Microbiol 44 (1990) 531-553
23. Duc L.H., Hong H.A., Uyen N.Q., and Cutting S.M. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine 22 (2004) 1873-1885
24. Kang T.J., Fenton M.J., Weiner M.A., Hibbs S., Basu S., Baillie L., et al. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun 73 November (11) (2005) 7495-7501